Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative
disorders characterized by different clinical courses, varying from indolent to highly …

Artificial intelligence (AI) is a growing field of research that is emerging as a promising
adjunct to assist physicians in detection and management of patients with cancer. 18 F-FDG …

Simple Summary Sinonasal cancers are rare types of cancer that are often detected at a late
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …

This study investigates whether baseline 18F-FDG PET radiomic features can predict
survival outcomes in patients with diffuse large B-cell lymphoma (DLBCL). We …

Exosomes, nanometer-sized membranous vesicles in body fluids, have emerged as
promising non-invasive biomarkers for cancer diagnosis. However, the function of exosomes …

Imaging in hematological diseases has evolved extensively over the past several decades.
Positron emission tomography/computed tomography (PET/CT) with of 2-[18 F]-fluoro-2 …

Simple Summary Positron emission tomography (PET); typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With PET …

Purpose For the identification of high-risk patients in diffuse large B-cell lymphoma (DLBCL),
we investigated the prognostic significance of in vivo radiomics derived from baseline [18F] …

Objective In this study, based on PET/CT radiomics features, we developed and validated a
nomogram to predict progression-free survival (PFS) for cases with diffuse large B cell …

Purpose Treatment strategies of lymphoid malignancies have been revolutionized by
immunotherapy. Because of the inherent property of Hodgkin lymphoma and some subtypes …